Biora Therapeutics, Inc.
BIORQ
$0.1174
-$0.0086-6.83%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -74.57% | -79.87% | -64.48% | -50.10% | -66.08% |
| Total Receivables | 6.11% | 0.37% | -0.72% | 0.24% | -1.21% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -38.82% | -32.31% | -26.12% | -32.77% | -41.79% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -98.32% | -84.97% | -94.00% | -81.47% | -10.96% |
| Total Current Assets | -68.55% | -72.85% | -62.14% | -49.97% | -58.48% |
|
|
|||||
| Total Current Assets | -68.55% | -72.85% | -62.14% | -49.97% | -58.48% |
| Net Property, Plant & Equipment | -28.79% | -23.26% | -31.78% | -11.67% | -22.38% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -38.54% | 5.65% | 13.13% | 50.25% | 38.33% |
| Total Assets | -58.20% | -63.23% | -56.82% | -41.68% | -44.58% |
|
|
|||||
| Total Accounts Payable | 77.11% | 48.99% | 44.24% | -21.16% | 65.75% |
| Total Accrued Expenses | 49.07% | 15.01% | 51.01% | 59.00% | 29.57% |
| Short-term Debt | -21.69% | 10.94% | 20.72% | -9.89% | -46.51% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3,986.17% | 244.94% | 225.39% | 221.61% | -22.04% |
| Total Finance Division Other Current Liabilities | 8.65% | 11.19% | 138.38% | 256.49% | 288.74% |
| Total Other Current Liabilities | 8.65% | 11.19% | 138.38% | 256.49% | 288.74% |
| Total Current Liabilities | 73.44% | 22.10% | 103.74% | 170.21% | 153.89% |
|
|
|||||
| Total Current Liabilities | 73.44% | 22.10% | 103.74% | 170.21% | 153.89% |
| Long-Term Debt | -- | -65.96% | -66.24% | -65.78% | -36.93% |
| Short-term Debt | -21.69% | 10.94% | 20.72% | -9.89% | -46.51% |
| Capital Leases | -67.94% | -64.33% | -56.17% | 36.11% | 62.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -92.89% | 446.07% | 674.36% | 513.19% | -44.99% |
| Total Liabilities | -21.08% | -36.92% | -22.16% | -14.87% | -4.10% |
|
|
|||||
| Common Stock & APIC | 5.23% | 15.54% | 15.25% | 16.81% | 13.76% |
| Retained Earnings | -3.37% | -10.04% | -13.13% | -15.01% | -15.06% |
| Treasury Stock & Other | 0.01% | -0.01% | -0.01% | -0.01% | 0.02% |
| Total Common Equity | 10.23% | 26.11% | 4.58% | 0.85% | -21.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.23% | 26.11% | 4.58% | 0.85% | -21.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.23% | 26.11% | 4.58% | 0.85% | -21.90% |
|
|
|||||
